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Abstract. The paper proposes a learning approach to support med-
ical researchers in the context of in-vivo cancer imaging, and specifically
in the analysis of Dynamic Contrast-Enhanced MRI (DCE-MRI) data.
DCE-MRI techniques are applied to monitor the development of the
tumour micro-vessels. Tumour heterogeneity is characterized by iden-
tifying regions with different vascular perfusion. The overall aim is to
measure volume differences of such regions for two experimental groups:
the treated group, to which an anticancer therapy is administered, and
a control group. In this way a non-invasive method for the analysis of
the treatment efficacy is obtained. The proposed approach is based on
a three-steps procedure: (i) robust features extraction from raw time-
intensity curves, (ii) sample-regions identification manually traced by
medical researchers on a small portion of input data, and (iii) overall
segmentation by training a Support Vector Machine (SVM) to classify
the MRI voxels according to the previously identified cancer areas. In
particular, after this phases the SVM is able to classify unseen subjects
with the same kind of tumour. Results obtained in the present work
report convincing analysis of tumour heterogeneity by allowing quanti-
tative measurements of volumetric changes within the identified tumoral
regions. The evaluation of such differences between the two experimental
groups, is useful for an efficacy study of the anticancer therapies.
1 Introduction
In the context of cancer imaging, machine learning techniques are becoming
important to automatically isolate areas of interest characterized by heteroge-
neous tumoural tissues. In particular, the identification of tumour heterogeneity
is crucial for diagnosis and therapy assessment. In this paper, tumour morphol-
ogy and functional perfusion are obtained by Dynamic Contrast Enhanced MRI
(DCE-MRI) techniques. We propose a learning-by-example approach[1] to clas-
sify tumoral regions characterized by heterogeneous vascular perfusion. In fact,
DCE-MRI techniques represent noninvasive ways to assess tumour vasculature,
that are accepted surrogate markers of tumour angiogenesis [2]. Data are ana-
lyzed with the aim of investigating the volume changes in the identified regions
for both untreated and treated tumours. As a result, a method for in-vivo eval-
uation of treatment efficacy becomes available to assess anticancer therapies.
The proposed analysis is based on three main phases: (i) features extraction from
raw time-intensity curves, (ii) representative tumour areas identification, and (iii)
overall voxel-by-voxel classification. In the first phase, few robust features that
compactly represent the response of the tissue to the DCE-MRI analysis are
computed. The second step provides a manual identification of tumour samples
that are representative of the typical tumour aspects. Such samples are carefully
and manually chosen by a medical researcher on a small portion of input data
by observing the different behavior of the time-intensity signals within different
kind of tumoural regions (i.e., necrotic or still alive zones). Finally, in the third
step, a Support Vector Machine (SVM) is trained to classify voxels according
to the regions (i.e., typologies of tumour tissue) defined by the previous phase.
In this way, the SVM is able to automatically detect the most discriminative
characteristics of the manually identified regions by extending such capability to
classify unseen subjects.
Several works are based on the use of machine learning techniques for DCE-
MRI tumour analysis [3–6]. In [3], a visual data-mining approach is proposed
to support the medical researchers in tumoral areas characterization by clus-
tering data according to the transendothelial permeability (kPS) and fractional
plasma volume (fPV). Although kPS and fPV are accepted estimate of tissue
vasculature, it is proved their instability under small perturbation of the cho-
sen pharmacokinetics model [4, 5]. Therefore, different works are addressed the
idea of analyzing directly the raw signals by exploiting possible other compact
parameters of the curve shapes. As an example, in [4] the raw signals of the
DCE-MRI voxels are analyzed in the context of musculoskeletal tissue classi-
fication. Several features are extracted to represent the signals shape such as
the maximum signal intensity, the largest positive signal difference between two
consecutive scans, and so on. Then, the classification is carried out by intro-
ducing a thresholding approach. In [5] the authors propose the use of the Mean
Shift algorithm [7] for the clustering of breast DCE-MRI lesions. In particular,
voxels are clustered according to the area under the curve feature. Since the re-
sults are over-segmented, an iterative procedure is introduced to automatically
select the clusters which better represent the tumour. Similarly, in our previous
work [8], tumoral regions are characterized by combining Mean Shift clustering[7]
with Support Vector Machine (SVM) classification. In [6] a learning-by-example
approach is introduced to detect suspicious lesions in DCE-MRI data. The tu-
moural pixels are selected in a supervised fashion and fed to a SVM which is
trained to perform a binary classification between healthy and malignant pixels.
The raw n-dimensional signal is used as multidimensional vector.
In the present work we extend the basic framework proposed in [8], to asses
the treatment efficacy of anticancer therapies. The above described analysis is
applied on two groups of animals (treated and control) at two time points (i.e.,
T0 and T1). At the end of the treatment period (time point T1) the differences in
tumour evolutions between the two groups were assessed by measuring volumet-
ric differences on the various detected regions. The rest of the paper is organized
as following. Section 2 introduces the experimental design and data acquisition
process. Section 3 describes the proposed method by detailing the main phases
involved on the proposed framework. Exhaustive results are shown and discussed
in Section 4, and finally conclusions are drawn in Section 5.
2 Materials
2.1 Experimental design
Tumours were induced by subcutaneous injection of human carcinoma cells in
nude mice (n = 11). Ten days after cells injection animals were randomly as-
signed to the treated (n = 6) and control group (n = 5). Animals belonging to
the treated and control group received an experimental drug and vehicle, respec-
tively, for a period of 7 days. All animals were observed by MRI before (time T0)
and after the treatment (time T1). A further group of mice (n = 5) bearing the
same kind of tumour was used in the training step of the classification procedure.
2.2 Data acquisition
Animals were examined using DCE-MRI with MS-325 (Vasovist R©, Schering
Germany) as contrast agent. Mice were anesthetized by inhalation of a mixture of
air and O2 containing 0.5−1% isofluorane, and placed in a prone position inside
a 3.5 cm i.d. transmitter-receiver birdcage coil. Images were acquired using a
Biospec tomograph (Bruker, Karlsruhe, Germany) equipped with a 4.7 T, 33 cm
bore horizontal magnet (Oxford Ltd., Oxford, UK ). DCE-MRI experiments were
performed as previously described [2, 9, 10]. Briefly, after tumour localization,
a dynamic series of transversal spoiled-gradient echo (SPGR) 3D images were
acquired with the following parameters: repetition time/echo time 50/3.5 ms, flip
angle (90◦), matrix size 256×128×16, field-of-view 6×3×2.4 cm3 (corresponding
to 0.234 × 0.234 mm2 in-plane resolution and 1.5 mm slice thickness), number
of acquisitions = 1. The acquisition time for a single 3D image was 102 seconds;
dynamic scans of 25 images were acquired at 5-second intervals (total acquisition
time approximately 45 minutes). The contrast agent was injected in bolus during
the time interval between the first and the second scan at 100 µmol/kg dosage.
3 Proposed Method
At each time point, signal intensity values have been normalized to the pre-
contrast value and filtered using a smoothing function to minimize fluctuations
due to movement artefacts or noise. To account for tumour heterogeneity, seven
classes have been fixed by combining a-priori knowledge of medical experts with
the observation of signal shape behaviors (see A-G in Figure 1):
Fig. 1. Sample regions used for SVM training. To account for tumour heterogeneity
seven classes (A-G) were chosen by a-priori knowledge. Source data used to select the
sample regions (TOP), and the relative DCE-MRI curves of the whole training set are
reported (BOTTOM).
– Classes A and D, are characterized by contrast agent wash-out (i.e., clear
defined peak followed by a decrease). These regions correspond to highly
vascularized and viable tumor tissue. Regions A and D differ by the value of
maximum intensity.
– Classes B and E, reveal contrast agent accumulation (i.e., increasing trend).
Presumably, this areas correspond to viable tissue with reduced vasculariza-
tion, evidencing the transition of the tumor toward a necrotic state. Again,
regions B and E differs by the value of maximum intensity.
– Class C, contains voxels with negligible enhancement, typically due to necrotic
and not vascularized tissue.
– Classes F and G, have been introduced to account for intermediate patterns
(i.e., initial increasing trend followed by a plateau phase).
By following the proposed pipeline, few and stable signal features are iden-
tified to model the different DCE-MRI curve classes. In particular the follow-
ing curve characteristics are chosen: time-to-peak (TTP ), peak value (PEAK),
area under curve (AUC), initial area under curve (AUCTTP ), and wash-out
rate (WR) (see Figure 2). Therefore, in order to apply a learning-by-example
approach, several samples of each identified class need to be fed to the classifier.
As mentioned above, such phase is carried out manually by medical experts.
Figure 1(TOP) shows some representative regions which are used to build the
training set. In Figure 1(BOTTOM) the signals curve of the whole selected
samples are reported. Signals are colored according to their respective class by
evidencing the expected curve shape.
Fig. 2. Example of some features extracted from time-series (TTP , AUCTTP , WR)
A binary Support Vector Machine (SVM) [11] classifier is used to distinguish
among the several tumoral tissue classes. SVM constructs a maximal margin
hyperplane in a high dimensional feature space, by mapping the original fea-
tures through a kernel function. Since the Radial Basis Function (RBF) kernel
has been used, two parameters C and γ need to be estimated. As previously
suggested [12], data are properly normalized and parameters are estimated by
combining grid search with leave-one-out cross-validation [1]. In order to extend
the SVM to a multi-class framework, the one-against-all approach is carried out
[1]. In our framework, such learning-by-example approach is introduced to bet-
ter generalize the results. In fact, the SVM is able to automatically detect the
most discriminative characteristics of the manually identified regions therefore
allowing also the classification of new subjects.
The effect of the previously selected features in the classification have been
assessed by comparing the results obtained by using (i) only two (PEAK and
TTP ) features, (ii) all the five features and (iii) directly the raw n-dimensional
time-series. The accuracy of the training phase of the SVM has been 89.1%,
95.4% and 99.8% using two features, five features and raw signals, respectively.
This comparison allows a better identification of the most discriminative features
by possible introducing a model selection phase.
Finally, in each tumour, the percentage volumes covered by each of the seven
classes have been calculated to evaluate the time-dependent changes in control
and treated tumours. The values obtained have been averaged over the experi-
mental groups and statistically compared by paired t-test.
4 Results
The rate of tumour growth is strongly affected by the treatment; in fact average
tumour volume, as determined by MR images, increased from 575±104 mm3 to
1821±191 mm3 in the control group and from 553±187 mm3 to 788±227 mm3 in
the treated group. Table 1 summarizes the results of quantitative analysis in the
treated and control groups. For each animal, the percentage volume attributed
by the SVM classifier to each of the seven classes of signal intensity (S.I.) is
reported before treatment (time point T0) and after treatment (time point T1).
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0,1 0,3 37,0 32,2 0,3 13,5 0,1 2,1 0,7 32,6 60,7 13,8 1,0 5,5
1,7 1,4 12,4 22,5 4,6 5,7 2,6 2,5 8,2 9,2 68,3 56,2 2,3 2,5
6,0 11,4 12,8 20,4 0,1 8,7 1,6 2,3 1,2 18,4 74,2 32,8 4,1 6,0
4,3 7,1 4,9 16,0 0,6 4,6 1,7 2,7 3,8 23,7 83,6 38,3 1,2 7,6






14,3 9,0 13,1 12,6 1,5 4,4 4,9 3,0 4,5 9,4 58,7 55,6 3,1 6,0
1,2 4,8 28,6 39,9 0,6 4,2 0,7 1,6 3,4 12,0 60,0 34,1 5,5 3,5
3,4 13,5 34,1 19,1 0,3 1,5 3,3 3,9 3,4 10,6 50,0 43,4 5,5 8,0
12,1 5,2 8,4 26,3 0,2 2,4 2,4 1,1 1,4 4,0 73,4 56,6 2,2 4,4
5,0 11,2 21,0 23,2 4,8 4,3 6,7 8,0 8,6 13,6 47,0 30,0 6,8 9,7












0,1 0,4 32,4 23,7 3,3 22,7 0,1 1,2 3,3 27,1 58,8 18,3 2,0 6,7
3,3 1,8 13,2 20,9 7,5 6,8 2,0 1,4 6,3 11,3 63,4 53,7 4,3 4,1
4,4 10,0 7,3 17,2 0,4 8,6 1,2 2,0 2,9 18,3 77,6 36,4 6,2 7,4
8,3 8,2 7,7 15,3 1,6 9,1 2,8 2,0 2,9 19,4 74,2 37,2 2,5 8,9






18,0 12,0 10,9 11,3 2,1 4,9 4,0 2,9 4,2 11,1 53,9 50,5 6,9 7,3
1,3 4,5 19,5 29,8 2,7 5,5 0,5 1,0 10,0 11,7 58,0 40,9 8,1 6,6
2,9 16,8 24,2 20,7 0,7 3,7 3,2 3,9 4,1 12,5 56,8 31,3 8,2 11,1
15,7 4,3 11,7 16,7 0,3 8,6 2,9 1,0 2,1 9,0 63,6 55,0 3,6 5,4
5,2 13,3 16,4 20,0 5,1 7,8 5,6 9,2 7,4 16,3 49,7 19,5 10,5 13,9
2,5 7,1 21,1 10,4 4,4 8,8 1,6 2,7 8,2 9,8 56,3 56,4 5,9 4,8
Table 1. Percentage volume attributed by SVM classification algorithm to each of
the seven classes A-G in each subject at time T0 and at time T1. Results relative to
classification performed on rawdata and two features (TTP and PEAK) are shown.
Data reported in Table 1, averaged over the different experimental groups,
are shown in Figure 3A (relative to the classification obtained by using raw
data). In the control group there is a significant (p < 0.05) increase of the per-
centage volume covered by the classes C and E (i.e., the less enhancing portions
of the tumours). Concomitantly, a significant (p < 0.01) decrease of the class F is
observed. An increase in the scarcely enhanced tissue (mainly necrotic tissue) is
typically observed during fast tumour growth. The increase of this tissue is less
pronounced in treated tumours as expected from their reduced rate of growth.
The percentage volume attributed to A and D classes (wash-out regions that cor-
respond to well vascularized tissue) is not significantly affected by treatment (or
normal tumour growth) in agreement with the fact that the biological target of
the herein investigated therapeutic treatment is represented by tumour cells and
not by vasculature. Figure 3B shows percentage volumes of the different classes,
averaged over the whole experimental group, relative to the classification ob-
tained by using 2 features. Qualitatively, the alterations in percentage volumes of
the different classes between time T0 and T1 are in agreement with those reported
in Figure 3A, although there are some differences in their statistical significance.
In selected animals standard histological and CD31-immunohistochemical exam-
inations have been performed post-mortem according to [2]. These examinations
qualitatively confirm the main findings of the present study.
Fig. 3. Percentage volume (+ SD) attributed by the SVM to each of the seven classes
A-G averaged over the different experimental groups (control and treated). White bars
represent values at time T0, black bars at time T1. Data reported in (A) are relative to
the classification obtained by using rawdata; data reported in (B) are relative to the
classification obtained by using 2 features (PEAK and TTP ). Asterisks indicate t-test
significance at a 0.05 (*) and 0.01 (**) level comparing T0 vs T1.
The differences between percentage volumes of a given class obtained by using
raw data or two features (Table 1) are always less than 6% of the total volume.
Comparable results (data not shown) are observed by using all the five defined
features. These findings suggest that the identified features are able to summa-
rize correctly the discriminative characteristic of the original DCE-MRI signals
wrt the addressed classification problem. The stability of the method with regard
to the number of classes has not been tested at this stage.
Figure 4 shows segmentation of tumour images obtained with SVM in two
representative animals (vehicle and drug treated) before and after the treatment.
The substantial increase in the necrotic portion of the control tumour, typical
of fast growing tumours, can be visually appreciated.
Fig. 4. Segmentation of tumour images in representative control and treated tumours
at time T0 (LEFT) and at time T1 (RIGHT). The colorbar shows the colors used to
identify the segmented classes.
In order to evaluate the effectiveness of the proposed method, we compared
the regions obtained by SVM to those obtained by the standard k-means clus-
tering algorithm (here k = 7). Figure 5 shows representative results obtained
in two animals at time T1 when using both algorithms on raw time-series. Each
curve represents the time dependence of mean signal intensity over the extracted
clusters. Both algorithms detect the necrotic areas (scarcely enhanced tissue),
however whilst SVM is able to distinguish between wash-out and accumulation
regions, k-means depicts mainly regions with similar enhancement (see Figure 5
TOP). Moreover, also the meaning of the viable tumor areas is more clear when
regions are detected with SVM. In fact, by observing Figure 5 (BOTTOM) is
possible to infer the limited presence of highly vascular regions (i.e., classes A and
D) being the viable area mainly characterized by the intermediate class B. Such
considerations are not feasible from the k-means clustering. Nevertheless, with
SVM-based segmentation the identification of corresponding regions among dif-
ferent subjects is obtained by construction, as opposed to k-means clustering for
which such identification is not trivial (and in general for standard unsupervised
segmentation methods). Therefore, the use of a data-driven algorithm appears
unable to highlight regions with stable aspects and medical meaning, which can
be only detected by a learning-by-example algorithm, such as SVM.
Fig. 5. Clustering results obtained with k-means (TOP) and SVM (BOTTOM) in
two representative animals (time T1): one control (LEFT) and one treated (RIGHT).
The time-dependence of mean signal intensity for the extracted clusters is reported.
Tumoral regions detected with our approach satisfy better the expected properties and
the mean signal shapes are coherent with the taxonomy previously described.
5 Conclusions
In this paper we emphasize the use of a machine learning technique as a mean
to produce automatic and meaningful segmentation results in the quantitative
evaluation of DCE-MRI data. Specifically we have applied such technique in the
analysis of DCE-MRI data to assess the effect of treatment with an experimental
anticancer therapy. The SVM has been trained to detect biologically meaningful
tumour regions of contrast agent accumulation and wash-out, as well as regions
with negligible enhancement, attributable to necrotic tissue. The proposed ap-
proach permits the computation of percentage tumour volumes of above defined
regions and to follow their modifications during the treatment with an exper-
imental drug. The proposed comprensive experimental section have evidenced
the significative increase of necrotic volume on untreated subjects as confirmed
by histological validation. Our results suggest that this approach can be useful in
the analysis of heterogeneous tumour tissues and of their response to therapies.
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